查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球自动机械心肺復苏设备市场 - 2023-2030
市场调查报告书
商品编码
1373392

全球自动机械心肺復苏设备市场 - 2023-2030

Global Automatic Mechanical Cardiopulmonary Resuscitation Devices Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 186 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

机械心肺復苏术 (mCPR) 设备为心臟骤停 (SCA) 患者和其他病症患者提供自动胸外按压。这些设备的开发是为了实现自主循环（ROSC）的恢復，合理的例如手动心肺復苏术。然而，手动心肺復苏术容易出现人为错误和疲劳，而机械心肺復苏术几乎不需要人际关係，并且可以持续提供不变的高品质心肺復苏术。

因此，mCPR 设备越来越多地与手动 CPR 结合使用。 EMS 团队发现这项技术特别有利，因为自动、高品质的胸外按压为救援人员提供了时间来评估和治疗患者情况的进一步细节。此外，它还为移动救护车中的手动心肺復苏术提供了安全实用的选择。

市场动态：驱动因素与限制因素

心血管疾病的高盛行率

据估计，心血管疾病的高盛行率将在预测期内增加对自动机械心肺復苏术设备的需求。例如，根据英国心臟协会 2023 年报告，据估计，全球每 13 个人中就有 1 人患有心臟或循环系统疾病，全世界约有 6.2 亿人患有心臟和循环系统疾病，这个数字是由于生活方式的改变、人口老化和人口成长以及心臟病和中风的生存率提高，这一趋势将持续增长，如果这些趋势持续下去，预计该趋势将持续增长。

此外，2021年6月，根据世界卫生组织估计，2020年有1,790万人死于心血管疾病，占所有跨国死亡人数的32%，其中超过85%是由于心臟病和中风。超过四分之三的心血管疾病死亡发生在孟加拉、阿富汗等中低收入国家。2020 年，因非传染性疾病导致的 1700 万人过早死亡（70 岁以下）中，超过 38% 是由于CVD。此外，不断提高的意识、进步和市场发展等预计将有助于预测期内全球市场的成长。

设备成本高

自动机械心肺復苏设备的高成本预计将阻碍预测期内的全球市场成长。例如，自动 CPR 设备的平均成本为 10,000 美元。阻碍全球市场成长的其他因素包括缺乏熟练的专业人员和高昂的开发成本。

目录

第 1 章：方法与范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章：定义与概述

第 3 章：执行摘要

  • 按设备类型分類的片段
  • 电源片段
  • 最终使用者的片段
  • 按地区分類的片段

第 4 章：动力学

  • 影响因素
    • 司机
      • 心血管疾病的高盛行率
    • 限制
      • 设备成本高
    • 机会
    • 影响分析

第 5 章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 报销分析
  • 专利分析
  • 科技趋势
  • 流行病学
  • SWOT分析
  • DMI 意见

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆发前的情景
    • 新冠疫情期间的情景
    • 新冠疫情后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商策略倡议
  • 结论

第 7 章：按装置类型

  • 活塞装置
  • 负载分配装置
  • 3D设备

第 8 章：按电源

  • 气动驱动
  • 电池驱动
  • 机械驱动和电池驱动

第 9 章：最终用户

  • 医院
  • 专科诊所
  • 门诊手术中心 (ASC)
  • 紧急医疗服务（EMS）
  • 其他的

第 10 章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 亚太其他地区
  • 中东和非洲

第 11 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 12 章：公司简介

  • ZOLL Medical Corporation
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Michigan Instruments
  • Stryker
  • CPR Medical Devices, Inc.
  • Asahi Kasei Corporation
  • Defibtech LLC
  • Yantai Wanli Medical Equipment CO.,Ltd.
  • Schiller Healthcare
  • Sunlife Science
  • Ambulanc (Shenzhen) Tech.Co., Ltd.

第 13 章：附录

简介目录
Product Code: MD7160

Overview

Mechanical cardiopulmonary resuscitation (mCPR) devices deliver automated chest compressions to sudden cardiac arrest (SCA) sufferers and other conditions. These devices are developed to accomplish the recovery of spontaneous circulation (ROSC), reasonable such as manual CPR. Nevertheless, while manual CPR is subject to human blunder and exhaustion, mechanical CPR demands little human relations and can provide invariant high-quality CPR continuously.

Therefore, mCPR devices are increasingly being utilized in conjunction with manual CPR. EMS teams have encountered this technology specifically advantageous as the automated, high-quality chest compressions provide rescuers time to evaluate and treat further elements of the patient's situation. Further, it delivers a secure and practical option for manual CPR in a moving ambulance.

Market Dynamics: Drivers & Restraints

High Prevalence of Cardiovascular Disorders

The high prevalence of cardiovascular disorders is estimated to boost demand for automatic mechanical cardiopulmonary resuscitation devices during the forecast period. For instance, according to the British Heart Association Report 2023, worldwide it is assessed that 1 out of 13 individuals are living with a cardiac or circulatory disorder and about 620 million individuals are living with heart and circulatory diseases all over the world, this number is growing owing to altering lifestyles, an aging, and growing inhabitants, and enhanced survival rates from heart attacks and strokes and is expected to persist to advance if these tendencies persist.

Moreover, in June 2021, according to the World Health Organization, an assessed 17.9 million individuals died from CVDs in 2020, symbolizing 32% of all multinational casualties out of these deaths, over 85% were because of heart attack and stroke. More than three-quarters of CVD deaths surface in low and middle-income nations like Bangladesh, Afghanistan etc. Among the 17 million premature casualties (under the age of 70) owing to non-communicable conditions in 2020, over 38% were because of CVDs. Furthermore, growing awareness, advancements and market developments among others are expected to contribute to the global market growth during the forecast period.

High Device Cost

The high cost of automatic mechanical cardiopulmonary resuscitation devices is expected to hamper the global market growth during the forecast period. For instance, the average cost of an automated CPR device is US$ 10,000. Other factors hampering the global market growth include the deficiency of skilled professionals and high development costs.

Segment Analysis

The global automatic mechanical cardiopulmonary resuscitation devices market is segmented based on device type, power source, end user and region.

Battery-Driven CPR Devices Segment is Expected to Dominate Market

Owing to the increasing adoption of portable battery-powered automated CPR devices is expected to boost the battery-driven CPR devices market growth, dominating the global market during the forecast period. For instance, in November 2021, Horizon Health paramedics had a new, high-tech option to aid them in rescuing lives. Cardiac chest compressions that were earlier done manually, can currently be accomplished hands-free with the touch of a switch. The Horizon Health Foundation of East Central Illinois recently granted two automated CPR devices, known as AutoPulse. They are in expansion to the two AutoPulses properly in usage by the ambulance service.

Moreover, in March 2023, with a $121,835 federal grant to be used for the procurement of cardiopulmonary resuscitation (CPR) compression devices the East Haven Fire Department (EHFD) is hoping to rescue more additional lives thanks to the grant awarded via the Assistance to Firefighters Grant (AFG) program, which is part of the Federal Emergency Management Agency (FEMA). The $122,000 grant intends to supply the department with compression devices to be part of each of its unit's apparatuses that could eliminate hindrances to manually-performed CPR for those suffering from cardiac arrests and save more lives.

Geographical Analysis

North America is Expected to Dominate the Global Market

Owing to the growing cases of cardiovascular diseases, increasing efforts to raise awareness and market developments boosted the North America market growth thereby holding the majority of global market share. For instance, according to the Centers for Disease Control and Prevention, approximately 695,000 individuals in the U.S. died because of heart disorders in 2021 making up for 1 out of every 5 deaths.

Moreover, in May 2023, the American Heart Association executed the 49th Emergency Medical Services (EMS) Week, which delivered awareness to the cardiovascular patients regarding the CPR devices techniques. Furthermore, in April 2023, Defibtech, a U.S. manufacturer of life-saving medical tools, introduced the next evolution of their automated CPR device, the ARM XR. The ARM XR is planned for usage by emergency medical specialists to treat patients who are in cardiac arrest.

COVID-19 Impact Analysis:

COVID-19 has positively impacted the global automated mechanical CPR devices market as during the pandemic there was an increased need to deliver CPR to patients and a deficiency of professionals which in turn increased the demand for automated mechanical CPR devices. Moreover, increased demand and guideline constraints led to the development of advanced devices requiring minimal human interaction averting the risk of infection spread.

For instance, in March 2021, NHS Tayside-a Health Board and InnoScot Health, a healthcare corporation, united to design and create the device SARUS-CPR hood that was positioned to revolutionize the resuscitation approach for first responders. SARUS-CPR hood was adopted into clinical practice by NHS Tayside following its development in reaction to the COVID-19 pandemic.

Key Developments

  • In February 2022, CPR Therapeutics Inc., a medical device company obtained a U.S. patent for another element of technology that underlies its multimodal cardiopulmonary resuscitation (CPR) system: "Incorporation of the Electrodes for Defibrillation into the Patient-Facing Components of automated Cardiopulmonary Resuscitation Systems".
  • In September 2022, CPR Therapeutics Inc., a medical device company acquired a US$1.6M National Institutes of Health (NIH) National Heart Lung and Blood Institute (NHLBI) Direct-To-Phase II Small Business Innovation Research Award for its project "A Multimodal Integrated System for Improved Cardiopulmonary Resuscitation.".

Competitive Landscape

The major global players in the market include: ZOLL Medical Corporation, Michigan Instruments, Stryker, CPR Medical Devices, Inc., Asahi Kasei Corporation, Defibtech LLC, Yantai Wanli Medical Equipment Co., Ltd., Schiller Healthcare, Ambulanc (Shenzhen) Tech.Co., Ltd. And Sunlife Science among others.

Why Purchase the Report?

  • To visualize the global automatic mechanical cardiopulmonary resuscitation devices market segmentation based on device type, power source, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of automatic mechanical cardiopulmonary resuscitation devices market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global automatic mechanical cardiopulmonary resuscitation devices market report would provide approximately 61 tables, 59 figures and 186 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Device Type
  • 3.2. Snippet by Power Source
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. High Prevalence of Cardiovascular Disorders
    • 4.1.2. Restraints
      • 4.1.2.1. High Device Cost
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Patent Analysis
  • 5.7. Technology Trend
  • 5.8. Epidemiology
  • 5.9. SWOT Analysis
  • 5.10. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Device Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 7.1.2. Market Attractiveness Index, By Device Type
  • 7.2. Piston Devices*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Load Distribution Devices
  • 7.4. 3D Devices

8. By Power Source

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Power Source
    • 8.1.2. Market Attractiveness Index, By Power Source
  • 8.2. Pneumatically Driven*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Battery Driven
  • 8.4. Mechanically Actuated and Battery-Driven

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospital*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Clinics
  • 9.4. Ambulatory Surgical Centers (ASCs)
  • 9.5. Emergency Medical Service (EMS)
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Power Source
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Power Source
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Power Source
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Power Source
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Power Source
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. ZOLL Medical Corporation*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Michigan Instruments
  • 12.3. Stryker
  • 12.4. CPR Medical Devices, Inc.
  • 12.5. Asahi Kasei Corporation
  • 12.6. Defibtech LLC
  • 12.7. Yantai Wanli Medical Equipment CO.,Ltd.
  • 12.8. Schiller Healthcare
  • 12.9. Sunlife Science
  • 12.10. Ambulanc (Shenzhen) Tech.Co., Ltd.

LIST NOT EXHAUSTIVE.

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us